Business Wire
BusinessEli Lilly shares sit near $1,175, but a Yahoo Finance note points to relative performance as the case for the stockThe Apex TimesBusinessModerna and Merck report late-stage win for personalized melanoma vaccine with KeytrudaThe Apex TimesBusinessMicrosoft shares flash a fresh buy announcement after a breakout, reinforcing Wall Street’s AI focusThe Apex TimesBusinessTarget’s Digital Momentum Accelerates as Same-Day Delivery Gains TractionThe Apex TimesBusinessTesla to voluntarily recall about 3 million vehicles in China, citing door-handle and driver-monitoring issuesThe Apex TimesBusinessJPMorgan Warns of a Key “Demand vs. Spending” Test Ahead of IREN EarningsThe Apex TimesBusinessNovo Nordisk’s oral GLP-1 expansion in China intensifies the race for obesity drug pills, with Lilly filing earlierThe Apex TimesBusinessNike taps Walmart executive Jane Ewing as commercial chief, indicating a push to tighten internal alignmentThe Apex TimesBusinessModerna lifts fundraising to $2.6B as it pushes cancer programs while FDA clears updated COVID vaccinesThe Apex TimesBusinessNvidia’s valuation debate turns to Apple’s 2010s playbook, as the stock trades near a single-digit-style earnings multipleThe Apex TimesBusinessAmazon’s profit cushion is at a high point, but the path ahead may be bumpier, analysts warnThe Apex TimesBusinessYahoo Finance report says Peter Thiel shifted 33% of his portfolio toward three energy stocks, spotlighting his ties to PalantirThe Apex TimesBusinessEli Lilly shares sit near $1,175, but a Yahoo Finance note points to relative performance as the case for the stockThe Apex TimesBusinessModerna and Merck report late-stage win for personalized melanoma vaccine with KeytrudaThe Apex TimesBusinessMicrosoft shares flash a fresh buy announcement after a breakout, reinforcing Wall Street’s AI focusThe Apex TimesBusinessTarget’s Digital Momentum Accelerates as Same-Day Delivery Gains TractionThe Apex TimesBusinessTesla to voluntarily recall about 3 million vehicles in China, citing door-handle and driver-monitoring issuesThe Apex TimesBusinessJPMorgan Warns of a Key “Demand vs. Spending” Test Ahead of IREN EarningsThe Apex TimesBusinessNovo Nordisk’s oral GLP-1 expansion in China intensifies the race for obesity drug pills, with Lilly filing earlierThe Apex TimesBusinessNike taps Walmart executive Jane Ewing as commercial chief, indicating a push to tighten internal alignmentThe Apex TimesBusinessModerna lifts fundraising to $2.6B as it pushes cancer programs while FDA clears updated COVID vaccinesThe Apex TimesBusinessNvidia’s valuation debate turns to Apple’s 2010s playbook, as the stock trades near a single-digit-style earnings multipleThe Apex TimesBusinessAmazon’s profit cushion is at a high point, but the path ahead may be bumpier, analysts warnThe Apex TimesBusinessYahoo Finance report says Peter Thiel shifted 33% of his portfolio toward three energy stocks, spotlighting his ties to PalantirThe Apex TimesBusinessEli Lilly shares sit near $1,175, but a Yahoo Finance note points to relative performance as the case for the stockThe Apex TimesBusinessModerna and Merck report late-stage win for personalized melanoma vaccine with KeytrudaThe Apex TimesBusinessMicrosoft shares flash a fresh buy announcement after a breakout, reinforcing Wall Street’s AI focusThe Apex TimesBusinessTarget’s Digital Momentum Accelerates as Same-Day Delivery Gains TractionThe Apex TimesBusinessTesla to voluntarily recall about 3 million vehicles in China, citing door-handle and driver-monitoring issuesThe Apex TimesBusinessJPMorgan Warns of a Key “Demand vs. Spending” Test Ahead of IREN EarningsThe Apex TimesBusinessNovo Nordisk’s oral GLP-1 expansion in China intensifies the race for obesity drug pills, with Lilly filing earlierThe Apex TimesBusinessNike taps Walmart executive Jane Ewing as commercial chief, indicating a push to tighten internal alignmentThe Apex TimesBusinessModerna lifts fundraising to $2.6B as it pushes cancer programs while FDA clears updated COVID vaccinesThe Apex TimesBusinessNvidia’s valuation debate turns to Apple’s 2010s playbook, as the stock trades near a single-digit-style earnings multipleThe Apex TimesBusinessAmazon’s profit cushion is at a high point, but the path ahead may be bumpier, analysts warnThe Apex TimesBusinessYahoo Finance report says Peter Thiel shifted 33% of his portfolio toward three energy stocks, spotlighting his ties to PalantirThe Apex TimesBusinessEli Lilly shares sit near $1,175, but a Yahoo Finance note points to relative performance as the case for the stockThe Apex TimesBusinessModerna and Merck report late-stage win for personalized melanoma vaccine with KeytrudaThe Apex TimesBusinessMicrosoft shares flash a fresh buy announcement after a breakout, reinforcing Wall Street’s AI focusThe Apex TimesBusinessTarget’s Digital Momentum Accelerates as Same-Day Delivery Gains TractionThe Apex TimesBusinessTesla to voluntarily recall about 3 million vehicles in China, citing door-handle and driver-monitoring issuesThe Apex TimesBusinessJPMorgan Warns of a Key “Demand vs. Spending” Test Ahead of IREN EarningsThe Apex TimesBusinessNovo Nordisk’s oral GLP-1 expansion in China intensifies the race for obesity drug pills, with Lilly filing earlierThe Apex TimesBusinessNike taps Walmart executive Jane Ewing as commercial chief, indicating a push to tighten internal alignmentThe Apex TimesBusinessModerna lifts fundraising to $2.6B as it pushes cancer programs while FDA clears updated COVID vaccinesThe Apex TimesBusinessNvidia’s valuation debate turns to Apple’s 2010s playbook, as the stock trades near a single-digit-style earnings multipleThe Apex TimesBusinessAmazon’s profit cushion is at a high point, but the path ahead may be bumpier, analysts warnThe Apex TimesBusinessYahoo Finance report says Peter Thiel shifted 33% of his portfolio toward three energy stocks, spotlighting his ties to PalantirThe Apex Times
Back to front
Intel’s turnaround narrative faces a simple test, whether its factories stop losing money on internal supply
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 28, 11:17 AM EDT

Intel’s turnaround narrative faces a simple test, whether its factories stop losing money on internal supply

A recent market analysis argues Intel’s stock valuation is implicitly betting that losses tied to manufacturing wafers for the company’s own chips can be contained, despite the fact that its factories still generate losses on production that is largely sold to Intel.

3 min readEditor-approved Apex article

Intel has spent the past several years trying to reframe its long-running manufacturing challenge as a strategic advantage, with more focus on tightening process execution, expanding foundry-style output, and improving the economics of chip production. But one recurring question for investors is whether Intel can make its factory business financially self-supporting, especially for wafers that are produced primarily to supply Intel’s own products.

In a market analysis published by Yahoo Finance and carried by Trefis on August 28, the central claim is that Intel’s factories are still losing money on wafers, and that much of that wafer output is sold to Intel itself. The analysis suggests that this cost structure matters for the company’s broader turnaround because investors looking at Intel’s equity are paying for an expectation that the wafer-loss problem will improve.

The piece frames the stock market’s valuation as a bet on change rather than a reflection of current factory profitability. Put differently, the analysis argues that Intel’s multiple likely assumes that losses tied to manufacturing its own chips will shrink over time, even if the factory economics look weaker today. The analysis does not, in the available text, provide new guidance or specific financial targets for wafer-level profitability, focusing instead on what the stock price may be pricing in.

That distinction matters because Intel’s business model is unusual compared with a pure-play fabless chip designer. Intel has historically combined product development with internal manufacturing. When the manufacturing side runs at a loss on the wafers that feed the company’s own chips, it can complicate the narrative for investors who want to see a clear path to sustainable margins across both the technology and manufacturing operations.

The same tension sits at the heart of Intel’s ongoing strategic messaging around its manufacturing roadmap and efforts to strengthen execution. Intel’s investor and communications efforts have increasingly emphasized process technology progress, performance per watt, and the goal of making manufacturing more competitive. At the industry level, improved factory utilization, better yields (the proportion of chips that pass testing), and more effective technology transitions are the levers that typically move wafer economics.

Still, the market analysis cited here does not specify the precise mechanisms or timing that would shift the economics, beyond the general idea that investors’ expectations likely rely on an improvement in the wafer-loss situation. It also does not outline concrete wafer-level profit figures or disclose whether Intel is already seeing measurable improvement in internal supply costs. Without additional detail, the argument is best read as valuation interpretation rather than a new operational disclosure.

For Intel, the practical takeaway is that the company’s turnaround will likely be judged not only by product milestones or revenue trends, but also by whether manufacturing losses associated with internal wafer demand are reduced. If wafer economics improve, Intel’s manufacturing side could become less of a drag on consolidated results. If they do not, the market may remain skeptical about how quickly Intel can restore margins and justify a higher valuation.

Why It Matters

  • If wafer-level losses persist, they can pressure Intel’s consolidated margins even when chip performance improves.
  • Valuation may remain sensitive to whether investors believe manufacturing economics are on a credible trajectory.
  • Intel’s ability to translate process progress into factory profitability could be a key determinant of sentiment.

Sources

Key Facts

  • A market analysis published August 28 argues Intel’s factories are still losing money on wafers.
  • The analysis says much of that wafer output is sold to Intel, making internal manufacturing economics central to the turnaround.
  • It suggests Intel’s stock multiple likely assumes that wafer-related losses will improve.
  • The material provided does not include new Intel guidance, wafer-level profitability metrics, or a specific timeline for improvement.

Technology Related